219 related articles for article (PubMed ID: 11267933)
1. Effect of smoking on serum pepsinogen I level depends on serological status of Helicobacter pylori.
Tatemichi M; Kabuto M; Tsugane S
Jpn J Cancer Res; 2001 Mar; 92(3):243-8. PubMed ID: 11267933
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive evaluation of Helicobacter pylori therapy: role of fasting or postprandial gastrin, pepsinogen I, pepsinogen II, or serum IgG antibodies.
Al-Assi MT; Miki K; Walsh JH; Graham DP; Asaka M; Graham DY
Am J Gastroenterol; 1999 Sep; 94(9):2367-72. PubMed ID: 10483993
[TBL] [Abstract][Full Text] [Related]
3. Changes with aging in gastric biomarkers levels and in biochemical factors associated with
Shan JH; Bai XJ; Han LL; Yuan Y; Sun XF
World J Gastroenterol; 2017 Aug; 23(32):5945-5953. PubMed ID: 28932086
[TBL] [Abstract][Full Text] [Related]
4. The new modified ABCD method for gastric neoplasm screening.
Park CH; Kim EH; Jung DH; Chung H; Park JC; Shin SK; Lee SK; Lee YC
Gastric Cancer; 2016 Jan; 19(1):128-35. PubMed ID: 25663259
[TBL] [Abstract][Full Text] [Related]
5. Serum pepsinogens, gastrin-17 and Helicobacter pylori antibody in the residents of two cities in china with distinct mortality rates of gastric cancer.
Zheng KC; Aoki K; Li XQ; Lin SG; Wu BS; Zhong WL; Chen TH; Lin S; You JW; Su C
Tohoku J Exp Med; 2012 Dec; 228(4):289-94. PubMed ID: 23117263
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori and Schistosoma japonicum co-infection in a Chinese population: helminth infection alters humoral responses to H. pylori and serum pepsinogen I/II ratio.
Du Y; Agnew A; Ye XP; Robinson PA; Forman D; Crabtree JE
Microbes Infect; 2006 Jan; 8(1):52-60. PubMed ID: 16260169
[TBL] [Abstract][Full Text] [Related]
7. Association between abnormal gastric function risk and Helicobacter pylori infection assessed by ELISA and 14C-urea breath test.
Gong Y; Wei W; Yuan Y
Diagn Microbiol Infect Dis; 2014 Dec; 80(4):316-20. PubMed ID: 25284372
[TBL] [Abstract][Full Text] [Related]
8. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
[TBL] [Abstract][Full Text] [Related]
9. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
[TBL] [Abstract][Full Text] [Related]
10. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
[TBL] [Abstract][Full Text] [Related]
11. Changes in serum pepsinogen, gastrin, and immunoglobulin G antibody titers in helicobacter pylori-positive gastric ulcer after eradication of infection.
Ohkusa T; Takashimizu I; Fujiki K; Araki A; Honda K; Shimoi K; Sakurazawa T; Horiuchi T; Suzuki S; Ariake K; Ishii K
J Clin Gastroenterol; 1997 Jul; 25(1):317-22. PubMed ID: 9412911
[TBL] [Abstract][Full Text] [Related]
12. [Basal concentrations of gastrin and pepsinogen I and II in gastric ulcer: influence of Helicobacter pylori infection and usefulness in the control of the eradication].
Bermejo F; Boixeda D; Gisbert JP; Sanz JM; Defarges V; Alvarez Calatayud G; Moreno L; Martín de Argila C
Gastroenterol Hepatol; 2001 Feb; 24(2):56-62. PubMed ID: 11247290
[TBL] [Abstract][Full Text] [Related]
13. Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: a longitudinal study.
Tu H; Sun L; Dong X; Gong Y; Xu Q; Jing J; Long Q; Flanders WD; Bostick RM; Yuan Y
Int J Cancer; 2015 Jan; 136(2):425-34. PubMed ID: 24895149
[TBL] [Abstract][Full Text] [Related]
14. Different etiological role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: a nested case-control study using IgG titer against Hp surface antigen.
Tatemichi M; Sasazuki S; Inoue M; Tsugane S;
Acta Oncol; 2008; 47(3):360-5. PubMed ID: 18347999
[TBL] [Abstract][Full Text] [Related]
15. Pepsinogen testing for evaluation of the success of Helicobacter pylori eradication at 4 weeks after completion of therapy.
Leja M; Lapina S; Polaka I; Rudzite D; Vilkoite I; Daugule I; Belkovets A; Pimanov S; Makarenko J; Tolmanis I; Lejnieks A; Boka V; Rumba-Rozenfelde I; Vikmanis U
Medicina (Kaunas); 2014; 50(1):8-13. PubMed ID: 25060199
[TBL] [Abstract][Full Text] [Related]
16. Serum anti-Helicobacter pylori immunoglobulin G titer correlates with grade of histological gastritis, mucosal bacterial density, and levels of serum biomarkers.
Tu H; Sun L; Dong X; Gong Y; Xu Q; Jing J; Yuan Y
Scand J Gastroenterol; 2014 Mar; 49(3):259-66. PubMed ID: 24329006
[TBL] [Abstract][Full Text] [Related]
17. Impact of Helicobacter pylori Immunoglobulin G Levels and Atrophic Gastritis Status on Risk of Metabolic Syndrome.
Takeoka A; Tayama J; Yamasaki H; Kobayashi M; Ogawa S; Saigo T; Hayashida M; Shirabe S
PLoS One; 2016; 11(11):e0166588. PubMed ID: 27851820
[TBL] [Abstract][Full Text] [Related]
18. [Serological Changes after Equivocal Helicobacter pylori-serology Test Findings Dependent on Gastric Secreting Ability].
Kim JH; Lee SY; Kwon HG; Lee SP; Kim JH; Sung IK; Park HS; Shim CS
Korean J Gastroenterol; 2017 Oct; 70(4):181-189. PubMed ID: 29060956
[TBL] [Abstract][Full Text] [Related]
19. Association between polymorphisms in glutathione S-transferase Mu3 and IgG titer levels in serum against Helicobacter pylori.
Tatemichi M; Iwasaki M; Sasazuki S; Tsugane S
J Hum Genet; 2009 Oct; 54(10):557-63. PubMed ID: 19696791
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of H. pylori infection and atrophic gastritis among symptomatic and dyspeptic adults in Kazakhstan. A hospital-based screening study using a panel of serum biomarkers.
Benberin V; Bektayeva R; Karabayeva R; Lebedev A; Akemeyeva K; Paloheimo L; Syrjänen K
Anticancer Res; 2013 Oct; 33(10):4595-602. PubMed ID: 24123036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
